Integer Corporation (ITGR) Business Metric Overview - Stocknear

Integer Corporation

NYSE: ITGR · Real-Time Price · USD
106.95
0.35 (0.33%)
At close: Sep 05, 2025, 3:59 PM
106.94
-0.01%
After-hours: Sep 05, 2025, 06:09 PM EDT

Integer Revenue Breakdown

Period Ending Jun 27, 2025 Mar 28, 2025 Dec 31, 2024 Sep 27, 2024 Sep 30, 2016 Jul 1, 2016 Apr 1, 2016
Cardiac Rhythm Management & Neuromodulation Revenue 172M 160.34M 495.52M 165.09M 148.27M 144.22M 133.65M
Cardiac Rhythm Management & Neuromodulation Revenue Growth +7.27% -67.64% +200.14% +11.34% +2.81% +7.91% n/a
Cardio And Vascular Revenue 286.86M 258.87M 708.57M 241.01M n/a n/a n/a
Cardio And Vascular Revenue Growth +10.81% -63.47% +194.00% n/a n/a n/a n/a
Other Markets Revenue 17.64M 18.18M n/a 25.31M n/a n/a n/a
Other Markets Revenue Growth -2.94% n/a n/a n/a n/a n/a n/a

Revenue by Geography

Period Ending Dec 30, 2016 Sep 30, 2016 Jul 1, 2016 Apr 1, 2016 Jan 1, 2016 Oct 2, 2015 Jul 3, 2015 Apr 3, 2015 Jan 2, 2015 Oct 3, 2014 Jul 4, 2014 Jan 3, 2014 Sep 27, 2013 Jun 28, 2013 Mar 29, 2013 Dec 28, 2012 Sep 28, 2012 Jun 29, 2012
Belgium Revenue 16.24M 14.26M 20.49M 18.17M 16.86M 12.3M 16.02M 17.37M 33.94M 13.72M 17.65M 13.77M 39.11M 37.66M 23.23M 53.51M 26.32M 28.11M
Belgium Revenue Growth +13.89% -30.43% +12.80% +7.77% +36.98% -23.18% -7.77% -48.82% +147.31% -22.25% +28.20% -64.80% +3.85% +62.15% -56.59% +103.34% -6.37% n/a
Puerto Rico Revenue 39.03M 41.74M 39.34M 39.13M 38.65M 26.82M 37.41M 34.02M 61.24M 34.58M 31.89M n/a n/a n/a n/a n/a n/a n/a
Puerto Rico Revenue Growth -6.51% +6.10% +0.55% +1.23% +44.13% -28.33% +9.99% -44.45% +77.08% +8.46% n/a n/a n/a n/a n/a n/a n/a n/a
Rest Of World Revenue 111.46M 83.9M 84.46M 72.82M 77.78M 35.97M 46.42M 39.42M 90.39M 47.07M 44.78M n/a n/a n/a n/a n/a n/a n/a
Rest Of World Revenue Growth +32.85% -0.66% +15.98% -6.38% +116.24% -22.50% +17.74% -56.39% +92.04% +5.09% n/a n/a n/a n/a n/a n/a n/a n/a
United States Revenue 192.87M 206.66M 204.09M 202.12M 184.28M 71.55M 75.04M 70.52M 158.45M 76.33M 77.76M n/a n/a n/a n/a n/a n/a n/a
United States Revenue Growth -6.68% +1.26% +0.97% +9.68% +157.57% -4.66% +6.42% -55.50% +107.58% -1.84% n/a n/a n/a n/a n/a n/a n/a n/a

Operating Expense Breakdown

Period Ending Jun 27, 2025 Mar 28, 2025 Dec 31, 2024 Sep 27, 2024 Jun 28, 2024 Mar 29, 2024 Dec 31, 2023 Sep 29, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jul 1, 2022 Apr 1, 2022 Dec 31, 2021 Oct 1, 2021 Jul 2, 2021 Apr 2, 2021 Dec 31, 2020 Oct 2, 2020 Jul 3, 2020 Apr 3, 2020 Dec 31, 2019 Sep 27, 2019 Jun 28, 2019 Mar 29, 2019 Dec 28, 2018 Sep 28, 2018 Jun 29, 2018 Mar 30, 2018 Dec 29, 2017 Sep 29, 2017 Jun 30, 2017 Mar 31, 2017 Dec 30, 2016 Sep 30, 2016 Jul 1, 2016 Apr 1, 2016 Jan 1, 2016 Oct 2, 2015 Jul 3, 2015 Apr 3, 2015 Jan 2, 2015
Selling, General, and Administrative Revenue 52.92M 38.89M 47.47M 33.85M 37.13M 37.84M 45.8M 42.1M 45.83M 41.89M 41.04M 38.2M 41.79M 39.56M 36.27M 34.27M 35.38M 35.5M 35.04M 3.61M 33.9M 36.46M 37.66M 32.94M 33.14M 34.96M 35.14M 34.09M 36.78M 41.24M 42.62M 39.73M 39.72M 39.5M 37.51M 36.27M 37.63M 41.89M 33.51M 22.31M 24.1M 22.61M 24.85M
Selling, General, and Administrative Revenue Growth +36.09% -18.07% +40.21% -8.81% -1.89% -17.38% +8.79% -8.13% +9.41% +2.07% +7.44% -8.59% +5.63% +9.08% +5.83% -3.14% -0.35% +1.33% +870.82% -89.35% -7.01% -3.20% +14.35% -0.63% -5.19% -0.53% +3.08% -7.31% -10.81% -3.24% +7.26% +0.02% +0.57% +5.30% +3.43% -3.62% -10.17% +25.01% +50.21% -7.45% +6.61% -9.01% n/a
Research and Development Revenue 14.24M 14.2M 10.61M 11.92M 16.1M 15.75M 13.26M 14.54M 16.88M 19.09M 13.84M 16.12M 14.87M 16.08M 12.74M 12.05M 13.74M 13.46M 10.59M 11.89M 12.75M 13.24M 11.81M 11.73M 11.4M 11.6M 10.16M 12.23M 12.94M 14.54M 15.34M 13.61M 12.89M 13.41M 12.64M 11.41M 13.64M 17.31M 13.09M 14.3M 13.06M 12.54M 9.88M
Research and Development Revenue Growth +0.27% +33.79% -10.98% -25.96% +2.23% +18.83% -8.82% -13.88% -11.57% +37.94% -14.15% +8.42% -7.54% +26.28% +5.69% -12.29% +2.06% +27.12% -10.96% -6.70% -3.74% +12.13% +0.68% +2.92% -1.72% +14.14% -16.96% -5.42% -11.03% -5.23% +12.74% +5.57% -3.89% +6.07% +10.79% -16.33% -21.18% +32.23% -8.47% +9.46% +4.13% +26.94% n/a